- Research works
- 38 ▼ 45% vs 2013–17
- Citations
- 483 12.6 per fractional work
- Top-10% rate
- 37.0% record average 16.5%
- Open access
- 32% world 28%
Not ranked overall: Croma Pharma (Austria) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 3.9×. Every wedge is a field page.
Which keywords describe research at Croma Pharma (Austria)?
By fractional works in all years, weighted toward what it does more of than the world: Wound Healing, Tissue Engineering, Dry Eye Disease, Ocular Surface, Chitosan, Nanoparticles, Epidemiology and Nanocomposites.
- Botulinum Toxin
- Hybrid Materials
- Dermal Fillers
- Biomaterials
- Vitreoretinal Surgery
- Macrophages
- Growth Factors
- Angiogenesis
- Mucosal
- Limbal Stem Cells
- Antibody-Catalyzed Ozone Formation
- Nasal
- Glaucoma
- Biomedical Applications
- Drug Delivery
- Nanocomposites
- Inflammation
- Ocular Surface
- Dry Eye Disease
- Epidemiology
- Wound Healing
- Tissue Engineering
- Nanoparticles
- Chitosan
- Oxidative Stress
- Complications
- Myopia
- Diabetes
- Intraocular Pressure
- Regeneration
- Corneal Regeneration
- Ozone Therapy
- Polymeric
- Catalysis
- Fibroblasts
- Macular Hole
- Anatomy
- Optical Coherence Tomography
- Hyaluronic Acid
- Biodegradable Polymers
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Wound Healing6▲ 74×5 topics
- Epidemiology4▲ 2.7×5 topics
- Tissue Engineering4▲ 17×5 topics
- Dry Eye Disease3▲ 237×1 topic
- Nanoparticles3▲ 6.3×5 topics
- Ocular Surface3▲ 237×1 topic
- Chitosan3▲ 137×2 topics
- Inflammation3▲ 3.2×6 topics
- Oxidative Stress3▲ 3.7×3 topics
- Nanocomposites2▲ 8.3×4 topics
- Complications2▲ 12×3 topics
- Drug Delivery2▲ 13×3 topics
- Myopia2▲ 93×2 topics
- Biomedical Applications2▲ 5.3×6 topics
- Diabetes2▲ 11×2 topics
- Glaucoma2▲ 34×3 topics
- Intraocular Pressure2▲ 52×2 topics
- Nasal2▲ 108×2 topics
- Regeneration2▲ 30×3 topics
- Antibody-Catalyzed Ozone Formation2▲ 442×1 topic
- Corneal Regeneration2▲ 174×1 topic
- Limbal Stem Cells2▲ 174×1 topic
- Ozone Therapy2▲ 442×1 topic
- Mucosal2▲ 179×1 topic
- Polymeric2▲ 179×1 topic
- Angiogenesis2▲ 12×2 topics
- Catalysis2▲ 5.8×3 topics
- Growth Factors2▲ 44×2 topics
- Fibroblasts2▲ 106×1 topic
- Macrophages2▲ 26×1 topic
- Macular Hole2▲ 178×1 topic
- Vitreoretinal Surgery2▲ 178×1 topic
- Anatomy2▲ 52×2 topics
- Biomaterials2▲ 21×4 topics
- Optical Coherence Tomography2▲ 36×2 topics
- Dermal Fillers1▲ 202×1 topic
- Hyaluronic Acid1▲ 202×1 topic
- Hybrid Materials1▲ 34×2 topics
- Biodegradable Polymers1▲ 23×2 topics
- Botulinum Toxin1▲ 45×2 topics
Which research topics does Croma Pharma (Austria) publish most on?
By volume in 2022–2025: Facial Rejuvenation and Surgery Techniques, Chronic Obstructive Pulmonary Disease (COPD) Research, Botulinum Toxin and Related Neurological Disorders and Body Contouring and Surgery.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Facial Rejuvenation and Surgery Techniques Dermatology 1 works
- 2 Chronic Obstructive Pulmonary Disease (COPD) Research Pulmonary and Respiratory Medicine 1 works
- 3 Botulinum Toxin and Related Neurological Disorders Neurology 0 works
- 4 Body Contouring and Surgery Surgery 0 works
- 5 Dermatologic Treatments and Research Dermatology 0 works
- 6 Antenna Design and Analysis Aerospace Engineering 0 works
- 7 Indoor and Outdoor Localization Technologies Electrical and Electronic Engineering 0 works
- 8 GNSS positioning and interference Aerospace Engineering 0 works
- 9 Sympathectomy and Hyperhidrosis Treatments Physiology 0 works
- 10 Sexuality, Behavior, and Technology Clinical Psychology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Croma Pharma (Austria)'s research output changed?
Output in 2018–2022 was 45% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.